Literature DB >> 25811209

Giant aneurysm of the right coronary artery and magnetic resonance coronary angiography.

Sebastian Sobczak, Bogdan Jegier, Ludomir Stefanczyk, Malgorzata Lidia Lelonek1.   

Abstract

Coronary artery aneurysm (CAA) is generally defined as coronary dilatation that exceeds the diameter of normal adjacent segments or the diameter of the patient's largest coronary vessel by 1.5 times. The prime cause of CAAs is atherosclerosis, and the most commonly affected artery is the right coronary artery. CAAs are quite commonly detected during X-ray coronary angiography. However, Coronary artery aneurysm (CAA) is generally defined as coronary dilatation that exceeds the diameter of normal adjacent segments or the diameter of the patient's largest coronary vessel by 1.5 times. The prime cause of CAAs is atherosclerosis, and the most commonly affected artery is the right coronary artery. CAAs are quite commonly detected during X-ray coronary angiography. However, giant CAAs, especially with the diameter exceeding 100 mm, are extremely rare. The treatment method of choice of giant CAAs is the excision of aneurysm with coronary artery bypass grafting. We present a case of a 41-year-old apparently healthy woman with a giant right CAA. This was detected by noninvasive methods, including magnetic resonance coronary angiography, and its maximum diameter exceeded 100 mm. In emergency, the aneurysmal sac was excised and the aortocoronary saphenous vein graft was performed. We also present a review of the published studies of giant CAAs with the diameter exceeding 100 mm.

Entities:  

Mesh:

Year:  2014        PMID: 25811209      PMCID: PMC6152565          DOI: 10.5144/0256-4947.2014.346

Source DB:  PubMed          Journal:  Ann Saudi Med        ISSN: 0256-4947            Impact factor:   1.526


Coronary artery aneurysm (CAA) is not an uncommon condition, but giant CAAs are extremely rare. CAA is generally defined as coronary dilatation that exceeds the diameter of normal adjacent segments or the diameter of the patient’s largest coronary vessel by 1.5 times. The most commonly affected coronary artery is the right coronary artery (RCA).1 The prime cause of CAAs is atherosclerosis.2 We present a case with a giant right CAA.

CASE

A 41-year-old apparently healthy white woman suffering from palpitations and New York Heart Association class III dyspnea for 12 months was referred to the Department of Cardiology. She had no history of Kawasaki disease, other connective tissue diseases, or chest trauma. Physical examination results were normal. No abnormalities were observed in blood tests and serum protein electrophoresis. The test for antinuclear antibodies was negative. Transesophageal echocardiography (TEE) revealed a huge tumor (100×90×80 mm) on the right cardiac border, compressing the right atrium, and the superior and inferior vena cava. Blood flow into the tumor cavity and a connection with RCA were detected, which suggested the diagnosis of RCA aneurysm. Sixty-four slice coronary computed tomography angiography (CTA) exposed a large pericardial mass (Figures 1 and 2) (102×85×82 mm) connected with RCA and strongly compressing the right atrium, and the superior and inferior vena cava. Other coronary arteries were normal, and there was no occlusive coronary artery disease.
Figure 1

Computed tomographic images of the left anterior descending artery.

Figure 2

Computed tomographic images of the right coronary artery.

To complete diagnosis, cardiovascular magnetic resonance (CMR) imaging and magnetic resonance coronary angiography (MRCA) were performed (Figures 3 and 4) confirming the diagnosis of RCA aneurysm. No luminal thrombus or calcification was observed. CMR also revealed the compression of the right atrium, and the superior and inferior vena cava.
Figure 3

Coronary magnetic resonance image of giant aneurysm in coronal section compressing the inferior vena cava and right ventricle.

Figure 4

Giant right coronary artery aneurysm in the coronal section of CMR compressing the right ventricle (showing relationship with aortic arch).

The patient was admitted to Cardiac Surgery Department in emergency. The procedure was realized via median sternotomy. Because of the size of the aneurysm, the femoral cardiopulmonary bypass cannulation - arterial (MEDTRONIC EOPA 77422) and atriocaval (Edwards Life sciences VEFM020) - were used. Following aortic cross-clamping, cold cardioplegic arrest was obtained and the giant aneurysm was possible to open (Figure 5). The aneurysmal sac was excluded by the closure of the proximal orifice with the 4–0 prolene and ligation of the artery distal to the aneurysm. There was no thrombus inside the aneurysm. Subsequently the aortocoronary saphenous vein graft was performed.
Figure 5

Giant aneurysm (big arrow) with direct contact with the proximal part of the right coronary artery (small arrow).

Histologically, the aneurysmal wall revealed atherosclerotic plaques. Postoperative transthoracic echocardiography showed the preserved ejection fraction of the left ventricle (EF=63%) and no segmental abnormalities of myocardial contractility. The postoperative course was uneventful, and the patient was discharged on the sixth postoperative day. Eighteen months after the procedure, the patient was asymptomatic and worked full time.

DISCUSSION

CAAs are noted in approximately 0.9% to 4.9% of patients undergoing coronary angiography and are more common in men. RCA is also the most common site for CAAs.1 The prime cause of CAAs is atherosclerosis, followed by Kawasaki disease, polyarteritis nodosa, systemic lupus erythematosus, infection, trauma, angioplasty, and congenital malformations. CAAs are also the complication of coronary artery stenting and have been increasingly reported as a complication of drug-eluting stenting. 2 Our patient had no history of Kawasaki disease, other connective tissue diseases, or chest trauma, and there was no coronary artery disease in coronary CTA and MRCA. The histopathologic examination of the excised aneurysm showed atherosclerotic plaques suggesting that her aneurysm had the most frequent background, atheromatosis. CAAs, especially giant CAAs, may be detected noninvasively with the use of echocardiography, computed tomography, and magnetic resonance imaging.3 We made a presumptive diagnosis using TEE, which was confirmed by performing coronary CTA, CMR, and MRCA. Coronary CTA showed no coronary artery disease, and MRCA revealed the precise anatomy, size, and position of aneurysm, which were helpful for defining the range of surgical procedure. According to ACCF/ACR/AHA/NASCI/SCMR 2010 Expert Consensus Document on CMR, MRCA may be used for identifying coronary artery anomalies and aneurysms. It may be particularly useful in younger individuals with signs or symptoms of myocardial ischemia for the purpose of identifying anomalous origins of coronary arteries.4 However, the gold standard for diagnosis of coronary aneurysms still remains x-ray coronary angiography.3 In the light of obtaining precise details from coronary CTA and MRCA, there was no need to perform x-ray coronary angiography in the described case. Treatment options in CAAs consist of medical, surgical, and percutaneous approaches. To prevent thromboembolic complications, antiplatelet and/or antithrombotic drugs should be considered.5 Excision of CAA with CABG is the most frequently performed procedure as the treatment of giant CAAs, especially with a diameter exceeding 50 mm.6 To the best of our knowledge, the biggest CAA with a maximum diameter of 180 mm was described by Gupta et al.7 We present a case of 102 mm aneurysm, which is one of the biggest described in the literature (Table 1). We believe that only 23 cases (including the described one) have been reported to date in the English literature, with a maximum diameter exceeding 100 mm. We assume that our case is the first case of an atheromatous giant CAA in quadragenarian female described so far.
Table 1

Reported cases of giant coronary artery aneurysms with a maximum diameter >100 mm.

AuthorYearSizeSexCoronaryPresentationCause

Gupta et al72010180MLADN/ACongenital
Kumar et al82006160FRCASVC syndromeFibromuscular dysplasia
Kim et al91997150FRCADyspnoeaAtherosclerotic
Zhang et al101988150FRCADyspnoeaCongenital
Lim et al111977150MRCADyspnoeaCongenital
Wei et al121986150FRCADyspnoeaCongenital
Burnside et al132012150FRCAMediastinal massMyxoid degeneration
Li et al142012144FLCxChest distressCAF
Li et al152005138MRCACHFCAF
130FLM+LADCHFCAF
Llera et al162010130FRCASTEMIPost-traumatic
Chazov et al171991120MRCAChest heavinessUnknown
Westaby et al181999120MRCAAnginaAtherosclerotic
110MRCAAngina, collapseAtherosclerotic
Hirooka et al192009120FLMCHFUnknown
Marla et al202009120MLCxAnginaAtherosclerotic
Sareyyupoglu et al212009114FRCACHFAtherosclerotic
Mignosa et al222004110MRCADysphagiaWilliams syndrome
Topalian et al232005110MRCAAnginaCystic medial necrosis
Vlachou et al242008110MRCANauseaUnknown
Keyser et al252012106MRCAAnginaAtherosclerotic
Konen et al 262001101MRCAFatigueUnknown

CAF: Coronary artery fistula, LAD: left anterior descending artery, LCx: left circumflex artery, CHF: congestive heart failure, LM: left main coronary artery, N/A: not available, RCA: right coronary artery, STEMI: ST-elevation myocardial infarction, SVC: superior vena cava, F: female, M: male

In conclusion, giant CAAs exceeding 100 mm are extremely rare, and MRCA is a useful noninvasive method in confirming diagnosis. This is also helpful in planning of surgical treatment without exposure to ionizing radiation or iodinated contrast medium particularly in young patients. It provides the precise anatomy, size, and position of aneurysm at least equivalent to x-ray coronary angiography.
  25 in total

1.  Giant right coronary aneurysm: CT angiographic and echocardiographic findings.

Authors:  E Konen; M S Feinberg; B Morag; V Guetta; A Shinfeld; A Smolinsky; J Rozenman
Journal:  AJR Am J Roentgenol       Date:  2001-09       Impact factor: 3.959

Review 2.  ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents.

Authors:  W Gregory Hundley; David A Bluemke; J Paul Finn; Scott D Flamm; Mark A Fogel; Matthias G Friedrich; Vincent B Ho; Michael Jerosch-Herold; Christopher M Kramer; Warren J Manning; Manesh Patel; Gerald M Pohost; Arthur E Stillman; Richard D White; Pamela K Woodard
Journal:  J Am Coll Cardiol       Date:  2010-06-08       Impact factor: 24.094

Review 3.  Coronary artery aneurysm: a review.

Authors:  Payam S Pahlavan; Feraydoon Niroomand
Journal:  Clin Cardiol       Date:  2006-10       Impact factor: 2.882

4.  Echocardiographic features of a giant congenital aneurysm of the right coronary artery.

Authors:  C C Zhang; L X Hu; S W Hsieh; J F Liu
Journal:  J Clin Ultrasound       Date:  1988-09       Impact factor: 0.910

5.  Giant congenital aneurysm of the right coronary artery.

Authors:  C H Lim; N C Tan; L Tan; C S Seah; D Tan
Journal:  Am J Cardiol       Date:  1977-05-04       Impact factor: 2.778

Review 6.  Giant coronary aneurysms exceeding 5 cm in size.

Authors:  Andreas Keyser; Michael K Hilker; Oliver Husser; Claudius Diez; Christof Schmid
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-04-14

7.  Giant coronary artery aneurysm complicated with aortic regurgitation.

Authors:  Kazunobu Hirooka; Taijyu Watanabe; Masahiro Ohnuki
Journal:  Ann Thorac Surg       Date:  2009-03       Impact factor: 4.330

Review 8.  Coronary artery aneurysms: a review of the natural history, pathophysiology, and management.

Authors:  Paul Cohen; Patrick T O'Gara
Journal:  Cardiol Rev       Date:  2008 Nov-Dec       Impact factor: 2.644

9.  Giant right coronary artery aneurysm presenting as a paracardiac mass.

Authors:  Simone G Ramos; Karina M A Mata; Carmen C S Martins; Antonio P Martins; Marcos A Rossi
Journal:  Cardiovasc Pathol       Date:  2007-09-12       Impact factor: 2.185

Review 10.  Coronary artery aneurysm: a review and hypothesis regarding etiology.

Authors:  Larry Nichols; Stephen Lagana; Anil Parwani
Journal:  Arch Pathol Lab Med       Date:  2008-05       Impact factor: 5.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.